The four WT1-mutated cases that belonged to AML-MR presented concomitant mutations in ASXL1 (n = 1), ASXL1 and U2AF1 (n = 1) or BCOR (n = 1) or had a history of MDS (n = 1). This evidence concerns the gene U2AF1 and acute myeloid leukemia.